Stories of torture, corporate greed, fraud, and misconduct are regular features of daily news coverage. For years, psychological scientists have tried to understand why ordinary and decent people are driven to commit such atrocious acts. Much of what we know on this topic can be traced to the work of one man: Stanley Milgram. Included […]
When the space shuttle Atlantis returns from the International Space Station it will mark the end of an era for American space travel. We will all be holding our breath for its final safe landing to end a brilliant 30 year career. Reflecting on this, Lawrence Klein, Vice President and Co-Founder of Thought Technology Ltd., recalls, […]
Children and adults with social withdrawal due to Fragile X syndrome, the most common cause of inherited intellectual disability and the most common known single gene cause of autism, may benefit from an experimental drug under study by pediatric neurologists at Rush Children’s Hospital at Rush University Medical Center. Rush is the only site in […]
An experimental drug to treat social withdrawal in children and young adults with autism is being studied in a clinical trial at the University of Illinois at Chicago’s Institute for Juvenile Research. Children with autism – or autism spectrum disorders – often have difficulty communicating and interacting with others. Although behavioral and psychological interventions are […]
Autism Speaks Weatherstone Pre-Doctoral Fellows M. Ali Bangash, a 2009 fellow, and Mehreen Kouser, a 2010 fellow, recently published new findings in the journal Cell that shed light on the biology of autism. Their research is based on a mouse model that mimics a human mutation of a gene that is known to be associated […]
Fred Hutchinson Cancer Research Center announced today that it is relaunching an online study to help people quit smoking. The study, called WebQuit, is enrolling adult smokers nationwide. Participation is free to eligible individuals. The goal of WebQuit, which began a year ago, is to improve the effectiveness of online smoking-cessation programs. Study director Jonathan […]
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications – quetiapine (Seroquel), a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer. The research is funded by a $10 million grant from the U.S. Agency for Healthcare Research Quality (AHRQ).
The International Society For Neurofeedback And Research (ISNR) will hold its 2011 annual conference in Phoenix, Arizona. ISNR conferences are the premier international meetings for healthcare professionals, students, teachers, and researchers who are interested in psychophysiology, particularly peripheral biofeedback, neurofeedback, and quantitative EEG (QEEG).
Recent Comments